Objective: To evaluate the efficacy, safety, and clinical impact of blinatumomab across the treatment continuum of B-cell acute lymphoblastic leukemia. Design: Systematic evidence synthesis of randomi

Objective: To describe an exceptionally rare occurrence of chronic myeloid leukemia developing in the setting of relapsed refractory classical Hodgkin lymphoma following multi line chemotherapy, and t

Objective: To evaluate efficacy, durability, and safety of next-generation chimeric antigen receptor T-cell therapies in relapsed or refractory acute lymphoblastic leukemia. Design: A systematic revie

Acute myeloid leukemia (AML) is a hematopoietic malignancy that typically presents with constitutional symptoms, cytopenias, and bleeding manifestations. Its presentation as a surgical abdomen with as